Erythropoietin-independent erythroid colony formation by bone marrow progenitors exposed to interleukin-11 and interleukin-8

Experimental Hematology

Volumn 33, Issue 11, 2005, Pages 1299-1308

  Corre Buscail, Isabelle ^a   Pineau, Danielle ^b   Boissinot, Marjorie ^a   Hermouet, Sylvie ^a,b,c  

^a INSERM   (France)

^b INSTITUT DE BIOLOGIE   (France)

^c NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD36 ANTIGEN; CYTOKINE; DRUG ANTIBODY; ERYTHROPOIETIN; INTERLEUKIN 11; INTERLEUKIN 11 ANTIBODY; INTERLEUKIN 8; JANUS KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; STAT5 PROTEIN; STEM CELL FACTOR; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ANTIGEN PURIFICATION; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; ERYTHROBLAST; ERYTHROCYTOSIS; ERYTHROID PRECURSOR CELL; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN INDUCTION; STROMA CELL;

BONE MARROW CELLS; CELL CULTURE TECHNIQUES; COCULTURE TECHNIQUES; CYTOKINES; ERYTHROID PROGENITOR CELLS; ERYTHROPOIETIN; HEMATOPOIETIC STEM CELLS; HUMANS; INTERLEUKIN-11; INTERLEUKIN-8; POLYCYTHEMIA VERA; SIGNAL TRANSDUCTION;

EID: 27544467595     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2005.07.002     Document Type: Article

References (29)

1. J.J. Michiels, T. Barbui, and G. Finazzi Diagnosis and treatment of polycythemia vera and possible future study designs of PVSG Leuk Lymphoma 36 2000 239 253
2. C. Butcher, and R.J. D'Andrea Molecular aspects of polycythemia vera (review) Int J Mol Med 6 2000 243 252
3. J.L. Spivak Polycythemia vera: myths, mechanisms, and management Blood 100 2002 4272 4290
4. R. Kralovics, F. Passamonti, and A.S. Buser A gain-of-function mutation of JAK2 in myeloproliferative disorders N Engl J Med 352 2005 1779 1790
5. C. James, V. Ugo, and J.P. Le Couedic A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera Nature 434 2005 1144 1148
6. R.L. Levine, M. Wadleigh, and J. Cools Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia and myeloid metaplasia with myelofibrosis Cancer Cells 7 2005 387 397
7. E.J. Baxter, L.M. Scott, and P.J. Campbell Cancer Genome Project. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders Lancet 365 2005 1054 1061
8. K. Geissler, L. Ohler, and M. Fodinger Interleukin-10 inhibits erythropoietin-independent growth of erythroid bursts in patients with polycythemia vera Blood 92 1998 1967 1972
9. S. Hermouet, A. Godard, and D. Pineau Abnormal production of interleukin (IL)-11 and IL-8 in polycythemia vera Cytokine 20 2002 178 183
10. Corre-Buscail I, Pineau D, Veau L, Boissinot M, Jacques Y, Hermouet S. Thrombosis-associated deregulation of bone marrow stroma-derived interleukin-11 in polycythemia vera. Haematologica (Submitted).
11. V.F. Quesniaux, S.C. Clark, K. Turner, and B. Fagg Interleukin-11 stimulates multiple phases of erythropoiesis in vitro Blood 80 1992 1218 1223
12. U.S. Schwertschlag, W.L. Trepicchio, K.H. Dykstra, J.C. Keith, K.J. Turner, and A.J. Dorner Hematopoietic, immunomodulatory and epithelial effects of interleukin-11 Leukemia 13 1999 1307 1315
13. S. Hermouet, I. Corre, and E. Lippert Interleukin-8 and other agonists of Gi2 proteins: autocrine/paracrine growth factors for human hemopoietic progenitors acting in synergy with colony stimulating factors? Leuk Lymphoma 38 2000 39 48
14. M. Imbert, R. Pierre, J. Thiele, J.W. Vardiman, R.D. Brunning, and G. Flandrin Polycythemia Vera E.S. Jaffe N.L. Harris H. Stein J.W. Vardinan World Health Organization (WHO) Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues 2001 IARC Press Lyon, France 32 34
15. J.-M. Freyssinier, C. Lecoq-Lafon, S. Amsellem, F. Picard, R. Ducrocq, and P. Mayeux Purification, amplification and characterization of a population of human erythroid progenitors Br J Haematol 106 1999 912 922
16. I. Dobo, P. Mossuz, and L. Campos Comparison of four serum-free, cytokine- free media for the analysis of endogenous erythroid colony (EEC) growth in polycythemia vera (PV) and essential thrombocythemia (ET) Hematol J 2 2001 396 403
17. I. Dobo, M. Donnard, and F. Girodon Standardization and comparison of endogenous erythroid colony assay performed with bone marrow or blood progenitors for the diagnosis of polycythaemia vera Hematol J 5 2004 161 167
18. I. Dobo, N. Boiret, and E. Lippert A standardized endogenous megakaryocytic/erythroid (EMC/EEC) colony assay for the diagnosis of essential thrombocythemia Haematologica 89 2004 1203 1208
19. S.R. Goan, I. Junghahn, and M. Wissler Donor stromal cells from human blood engraft in NOD/SCID mice Blood 96 2000 3971 3978
20. V. Ugo, C. Marzac, and I. Teyssandier Multiple signaling pathways are involved in erythropoietin-independent differentiation of erythroid progenitors in polycythemia vera Exp Hematol 32 2004 179 187
21. A.R. Moliterno, W.D. Hankins, and J.L. Spivak Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera N Engl J Med 338 1998 572 580
22. V. Lacronique, A. Boureux, and V.D. Valle A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia Science 14 1997 1309 1312
23. S.R. Weiler, S. Mou, and C.S. DeBerry JAK-2 is associated with the c-kit proto-oncogene product and is phosphorylated in response to stem cell factor Blood 87 1996 3688 3693
24. X. Du, and D.A. Williams Interleukin-11: review of molecular, cell biology and clinical use Blood 89 1997 3877 3908
25. F. Magrangeas, O. Boisteau, S. Denis, Y. Jacques, and S. Minvielle Negative cross-talk between interleukin-3 and interleukin-11 is mediated by suppressor of cytokine signalling-3 (SOCS-3) Biochem J 353 2001 223 230
26. F. Magrangeas, O. Boisteau, S. Denis, Y. Jacques, and S. Minvielle Negative regulation of onconstatin M signaling by suppressor of cytokine signaling (SOCS-3) Eur Cytokine Netw 12 2001 309 315
27. + progenitor cells from polycythemia vera patients: evidence for delayed determination Int J Oncol 23 2003 437 443
28. N.A. Bhowmick, A. Chytil, and D. Plieth TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia Science 303 2004 848 851
29. N.A. Bhowmick, E.G. Neilson, and H.L. Moses Stromal fibroblasts in cancer initiation and progression Nature 432 2004 332 337